Pharma Reviews: Sensex flat, Nifty ends above 8150; Sun Pharma, Reliance down

Sensex flat, Nifty ends above 8150; Sun Pharma, Reliance down. Stocks of auto, consumer durable, banking, FMCG and power sectors trading in ...
Read more: Sensex flat, Nifty ends above 8150; Sun Pharma, Reliance down

Pharma Reviews: UBM India Announces CPhI's 5th Annual InnoPack Pharma Confex

CPhI Conferences, a division of UBM India which hosts a number of successful pharmaceutical conferences, has announced the 5th Annual InnoPack ...
Read more: UBM India Announces CPhI's 5th Annual InnoPack Pharma Confex

US FDA News: FDA approves Ocaliva for rare, chronic liver disease

Today the U.S. Food and Drug Administration granted accelerated approval for Ocaliva (obeticholic acid) for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as a single therapy in adults unable to tolerate UDCA.
Read more: FDA approves Ocaliva for rare, chronic liver disease

Pharma Reviews: UPDATE 1-India's Sun Pharma forecasts annual sales below estimates, shares fall

MUMBAI, May 31 India's Sun Pharmaceutical Industries Ltd issued a weaker-than expected annual sales outlook as it grapples with increased ...
Read more: UPDATE 1-India's Sun Pharma forecasts annual sales below estimates, shares fall

Pharma Reviews: Torrent Pharma plans 50% hike in R&D spend, focuses on regulated mkts

The Rs 6,676 crore company is planning to increase its research and ... Torrent is one of the few Indian pharma companies which has not been ...
Read more: Torrent Pharma plans 50% hike in R&D spend, focuses on regulated mkts

Pharma Reviews: Opening Bell | Asian markets open mixed; Sun Pharma, Tata Motors in focus

The US Department of Justice (DoJ) has subpoenaed India's largest drug maker Sun Pharmaceutical Industries Ltd, seeking information about the ...
Read more: Opening Bell | Asian markets open mixed; Sun Pharma, Tata Motors in focus

Pharma Reviews: Government to conduct study to assess impact of FDI in pharma industry

The market size of the India's pharma industry is estimated at over $20 billion. NEW DELHI: The Commerce and Industry Ministry has commissioned a ...
Read more: Government to conduct study to assess impact of FDI in pharma industry

Sun Pharma gets US subpoena over generic drugs pricing

MUMBAI: The U.S. Department of Justice (DoJ) has subpoenaed India's largest drugmaker Sun Pharmaceutical Industries Ltd seeking information ...

from Google Alert - indian pharma industry http://ift.tt/1RBISaI